By Tom Zanki ( May 24, 2018, 8:55 PM EDT) -- Venture-backed biotechnology companies Kiniksa Pharmaceuticals Ltd. and Scholar Rock Holding Corp. debuted in public markets Thursday to strong investor receptions after completing initial public offerings that raised a combined $227 million, represented respectively by Latham & Watkins LLP and Goodwin Procter LLP....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.